Top Weekly Performers
Explore the top weekly stock winners for 21 Mar 2025, outperforming the market and delivering gains.
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$18.3B | 5.5 | $156.2 61.8% overvalued | 105.2% | $6,572.4M | $198.4M | 12.2% | 3.0% | 23.9% | 5.3% | 52.0% | |
$5,072.2M | 5.9 | $2.3 89.8% overvalued | 137.7% | $43.1M | ($123.7M) | 95.4% | (287.1%) | 52.2% | (228.3%) | 4.6% | |
$4,645.3M | 5.4 | $0.0 99.3% overvalued | (46.4%) | $202.0K | ($27.1M) | (86.2%) | (13,418.8%) | (233.2%) | 1,698.5% | 4.1% | |
$3,981.8M | 6.8 | $18.9 21.4% undervalued | (10.1%) | $1,108.8M | $46.4M | 35.8% | 4.2% | 28.8% | 14.0% | 7.4% | |
$3,427.5M | 5.4 | $1.8 41.2% overvalued | (43.4%) | R$131.5B | R$781.8M | 2.3% | 0.6% | 7.2% | 21.4% | 99.9% | |
$3,257.7M | 5.8 | $2.6 67.4% overvalued | 66.5% | $0.0 | ($450.6M) | (100.0%) | N/A | N/A | (468.4%) | 10.5% | |
$3,182.3M | 6.7 | $11.3 37.5% undervalued | 19.1% | $2,002.6M | $245.8M | 42.1% | 12.3% | 24.0% | 4.9% | 44.6% | |
$2,640.2M | 5.8 | $0.8 92.6% overvalued | 359.6% | $8,827.0K | ($46.1M) | 0.8% | (522.2%) | 63.0% | (547.9%) | 13.2% | |
$2,630.8M | 5.3 | $9.0 36.9% undervalued | 109.3% | $1,038.0M | ($8,954.0K) | 26.4% | (0.9%) | 27.9% | 1.1% | 53.6% | |
$2,506.2M | 5.8 | $0.4 96.2% overvalued | 405.4% | $10.8M | ($61.7M) | (10.2%) | (572.1%) | 36.2% | (126.1%) | 7.0% | |
$2,314.0M | 5.5 | $2.9 66.4% undervalued | (37.9%) | R$43.7B | R$1,758.7M | (2.0%) | 4.0% | 26.2% | 10.9% | 339.3% | |
$2,042.4M | 5.2 | $13.4 57.5% undervalued | 56.5% | $0.0 | ($790.2M) | (100.0%) | N/A | N/A | (7.9%) | 233.2% | |
$1,880.5M | 7.3 | $9.6 62.0% undervalued | 77.6% | $1,033.3M | $127.6M | 39.3% | 12.3% | 27.8% | 9.6% | 12.8% | |
$1,429.0M | 5.3 | $2.0 54.5% overvalued | 37.6% | $1,783.2M | $19.3M | (16.7%) | 1.1% | 48.6% | 12.5% | (1,556.2%) | |
$1,379.0M | 5.1 | $1.0 91.9% overvalued | 151.0% | $5,669.0K | ($38.8M) | 46.8% | (684.4%) | (113.4%) | (91.6%) | 33.5% | |
$1,192.7M | 6.1 | $0.5 95.4% overvalued | 160.4% | CA$0.0 | (CA$135.3M) | N/A | N/A | N/A | (92.9%) | 19.3% | |
$873.8M | 5.6 | $0.5 88.0% overvalued | (27.2%) | $398.8M | $20.9M | 4.2% | 5.2% | 59.5% | 5.7% | N/A | |
$716.3M | 5.6 | $0.4 96.0% overvalued | 173.4% | $0.0 | ($18.3M) | N/A | N/A | N/A | (45.9%) | 0.1% | |
$547.7M | 6.4 | $2.9 12.1% overvalued | (71.6%) | $399.2M | $72.0M | (18.4%) | 18.0% | 35.0% | 14.4% | 25.5% | |
$522.5M | 5.4 | $1.3 51.7% overvalued | (64.4%) | $86.9M | ($48.2M) | (12.5%) | (55.4%) | 49.1% | (66.9%) | 52.9% |
Improve returns with AI recommendations
Keep track of upcoming earnings reports from top companies
UNH
Last Price
503.8
1.0%Market Cap
$466.6B
6
total score
27.4%
undervalued
ORCL
Last Price
149.45
(3.0%)Market Cap
$428.6B
6
total score
25.0%
undervalued
ABBV
Last Price
213.85
(0.3%)Market Cap
$376.2B
6
total score
41.2%
undervalued
CSCO
Last Price
60.3
(1.0%)Market Cap
$237.9B
6
total score
27.3%
undervalued
ABT
Last Price
126.3
(1.0%)Market Cap
$218.2B
7
total score
42.3%
undervalued
TMO
Last Price
521.5
0.4%Market Cap
$197.5B
6
total score
25.0%
undervalued
Explore more stock ideas
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
High ROIC stocks
Discover high ROIC stocks in 2025 that generate returns on invested capital, driving sustainable growth and profitability.
3M Return 17.1%
S&P Outperformance 4.1%
Next 3M Predicted Return 6.4%
Low P/E stocks
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
3M Return 7.5%
S&P Outperformance 5.5%
Next 3M Predicted Return 10.2%